Comerica (NYSE:CMA) received mixed ratings from 16 financial analysts in the past three months, with an average 12-month price target of $53.03, reflecting an 8.05% increase from the previous target. Analysts' actions include raising, maintaining, and lowering ratings and price targets, indicating varied perspectives on Comerica's performance. The company faces challenges with a revenue decline of -9.04% over 3 months but shows strong financial health with a high net margin of 27.23% and an ROE of 4.99%. However, its ROA and high debt-to-equity ratio suggest areas of concern.